Clinical trial complexity has significantly increased in the past decade. How can the industry adapt and innovate to remain ...
E. Merck KG board of partners has announced the appointment of new CEOs to Merck KGaA’s executive board, aiding its ongoing growth strategy.
Product sales for the vaccine specialist Valneva reached €170m despite slow US sales of its chikungunya vaccine.
The EC has conditionally approved MSD's Welireg as a single agent for the treatment of adults with VHL disease and advanced ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results